PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
February 12, 2026Macromolecular Bioscience0 citations

Experimental and Finite Element Analysis of a Residual Hair Keratin‐based Hydrogel with Calcium for Atorvastatin Sequestration, Release, and In Vitro Activity

View Full Paper
ECEvan CarrollATAndrew TarabokijaHCHenna Chaudhry

Key Points

  • The study aims to evaluate keratin-based hydrogels for atorvastatin delivery and assess their physicochemical properties.
  • Developed keratin-based hydrogels using residual human hair and calcium incorporation.
  • Characterized hydrogels through chemical and charge property analysis, rheology, and porosity measurements.
  • Performed finite element analysis to validate release kinetics and estimate diffusivity.
  • Conducted in vitro assays to assess biocompatibility and atorvastatin bioactivity.
  • Hydrogels exhibited enhanced atorvastatin sequestration and controlled release kinetics.
  • Finite element analysis showed effective modeling of drug release profiles with high r^2 values.
  • Biocompatibility tests confirmed compliance with ISO standards, and atorvastatin maintained bioactivity in cell lines.

Abstract

ABSTRACT Excessive fibrosis impairs tissue regeneration by promoting extracellular matrix deposition and fibroblast activation. This study introduces keratin‐based hydrogels (KRT) derived from residual human hair as sustainable carriers for localized atorvastatin (Ator) delivery. Calcium incorporation (CKRT) enhanced electrostatic interactions with Ator, improving sequestration and modulating release kinetics. Comprehensive characterization of KRT included chemical composition (FTIR, DSC), charge properties (pI = 5.5; net negative charge = −15.43 µmol/g), porosity (89%), and rheology (shear‐thinning, linear viscoelastic region up to 24.5% strain, thermal stability to 68°C). Ator release followed Korsmeyer‐Peppas kinetics (r 2 > 95%), and finite element analysis validated experimental profiles (r 2 = 82%–95%) while estimating diffusivity reductions from 569 to 0.06 µm 2 /s within the gel matrix. In vitro assays confirmed CKRT biocompatibility (ISO 10993–5) and preserved Ator bioactivity, with EC 50 values of 208 µ m for mesenchymal stem and 389 µ m for fibroblast cell lines. These findings demonstrate that CKRT provides a robust platform for controlled anti‐fibrotic drug delivery, supported by extensive physicochemical and mechanical characterization.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Carroll et al. (2026) studied this question.

synapsesocial.com/papers/698d6e4a5be6419ac0d53dd1https://doi.org/10.1002/mabi.202500541
Ask AI
Helpful
Bookmark
Share
View Full Paper